v3.26.1
Condensed Statements of Changes in Shareholders’ Deficit (Unaudited) - USD ($)
Class A Ordinary Shares
Ordinary Shares
Class B Ordinary Shares
Ordinary Shares
 [1]
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2025 $ 575 $ 24,425 $ (45,622) $ (20,622)
Balance (in Shares) at Dec. 31, 2025 5,750,000      
Net income (41,408) (41,408)
Balance at Mar. 31, 2026 $ 575 24,425 (87,030) (62,030)
Balance (in Shares) at Mar. 31, 2026 5,750,000      
Balance at Dec. 31, 2025 $ 575 24,425 (45,622) (20,622)
Balance (in Shares) at Dec. 31, 2025 5,750,000      
Net income         444,673
Balance at Jun. 30, 2026 $ 500 (5,177,846) (5,177,346)
Balance (in Shares) at Jun. 30, 2026 5,000,000      
Balance at Mar. 31, 2026 $ 575 24,425 (87,030) (62,030)
Balance (in Shares) at Mar. 31, 2026 5,750,000      
Accretion for Class A ordinary shares to redemption amount (7,780,332) (5,576,897) (13,357,229)
Sale of Private Placement Warrants 5,375,000 5,375,000
Fair value of Public Warrants at issuance 2,565,000 2,565,000
Allocated value of transaction costs to Class A shares (184,468) (184,468)
Forfeiture of Founder Shares $ (75) 75
Forfeiture of Founder Shares (in Shares) (750,000)      
Compensation expense 300 300
Net income 486,081 486,081
Balance at Jun. 30, 2026 $ 500 $ (5,177,846) $ (5,177,346)
Balance (in Shares) at Jun. 30, 2026 5,000,000      
[1] Includes up to 750,000 Class B ordinary shares subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriters. On  May 18, 2026, the underwriters forfeited their over-allotment option. As a result, 750,000 Class B ordinary shares were forfeited, resulting in the Sponsor holding 4,925,000 Class B ordinary shares and the three independent directors holding 25,000 Class B ordinary shares each (see Note 8).